LifeTech Scientific Past Earnings Performance

Past criteria checks 1/6

LifeTech Scientific has been growing earnings at an average annual rate of 19.8%, while the Medical Equipment industry saw earnings growing at 10.9% annually. Revenues have been growing at an average rate of 17.4% per year. LifeTech Scientific's return on equity is 3.2%, and it has net margins of 20.8%.

Key information

19.8%

Earnings growth rate

19.6%

EPS growth rate

Medical Equipment Industry Growth	8.9%
Revenue growth rate	17.4%
Return on equity	3.2%
Net Margin	20.8%
Last Earnings Update	31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How LifeTech Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:LFTS.F Revenue, expenses and earnings (CNY Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
31 Dec 23	1,267	263	415	298
30 Sep 23	1,224	297	399	258
30 Jun 23	1,182	331	382	219
31 Mar 23	1,139	328	365	214
31 Dec 22	1,097	325	348	208
30 Sep 22	1,058	314	329	195
30 Jun 22	1,019	303	311	181
31 Mar 22	972	298	297	164
31 Dec 21	925	292	283	146
30 Sep 21	878	307	320	164
30 Jun 21	830	322	356	183
31 Mar 21	736	269	342	175
31 Dec 20	642	216	327	167
30 Sep 20	638	176	302	150
30 Jun 20	633	136	277	133
31 Mar 20	651	132	288	137
31 Dec 19	669	129	299	141
30 Sep 19	644	138	276	137
30 Jun 19	618	146	252	132
31 Mar 19	588	134	239	124
31 Dec 18	557	121	226	115
30 Sep 18	518	134	196	96
30 Jun 18	480	147	165	76
31 Mar 18	445	155	151	69
31 Dec 17	409	163	138	62
30 Sep 17	391	171	138	61
30 Jun 17	373	178	139	59
31 Mar 17	363	162	136	58
31 Dec 16	353	146	133	58
30 Sep 16	336	201	126	55
30 Jun 16	319	256	119	52
31 Mar 16	315	129	120	50
31 Dec 15	312	2	121	47
30 Sep 15	304	-41	123	42
30 Jun 15	296	-84	125	38
31 Mar 15	289	-83	135	35
31 Dec 14	283	-81	145	33
30 Sep 14	280	-151	151	35
30 Jun 14	258	-209	139	34
31 Mar 14	248	-89	130	33
31 Dec 13	231	-66	115	31
30 Sep 13	209	-53	101	27
30 Jun 13	201	-46	95	24

Quality Earnings: LFTS.F has a large one-off loss of CN¥177.9M impacting its last 12 months of financial results to 31st December, 2023.

Growing Profit Margin: LFTS.F's current net profit margins (20.8%) are lower than last year (29.6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: LFTS.F's earnings have grown by 19.8% per year over the past 5 years.

Accelerating Growth: LFTS.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: LFTS.F had negative earnings growth (-19.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (2.9%).

Return on Equity

High ROE: LFTS.F's Return on Equity (3.2%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/05/07 14:15
End of Day Share Price	2024/02/08 00:00
Earnings	2023/12/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

LifeTech Scientific Corporation is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yuan Gao	China International Capital Corporation Limited
Hanqing Zhu	Guosen Securities Co., Ltd.
Helena Qiu	Guosen Securities(HK) Financial Holdings Company